Home » Health Products,Drug and Medicine » Sofosbuvir Velpatasvir Tablets » Velakast Sofosbuvir And Velpatasvir Tablets
Velakast Sofosbuvir And Velpatasvir Tablets
₹ 6,000 / Bottle Get Latest Price
Product Specifications
| Brand | Velakast |
| Shelf life | 24 Months |
| Composition | Velpatasvir 100 mg and Sofosbuvir 400 mg |
| Packaging Type | Bottle |
| Treatment | The Hepatitis C Treatment Drug |
| Availability | In Stock |
| Brand | Velakast |
| Packaging Size | 28 Tablets |
| Manufacturer | Aprazer Healthcare |
| Dosage Form | Tablet |
| Storage | Store Below 25 Degree C |
GST No - 07BAJPC0326B1ZI | Member since 2026
SECOND FLOOR, OFFICE NO.01, PORTION-G, PLOT NO.37, BLOCK-8, Najafgarh Road, Kirti Nagar Industrial Area, New Delhi, West Delhi, Delhi, 110015
Velakast Sofosbuvir And Velpatasvir Tablets Read More...
Product Details
Velpatasvir & Sofosbuvir (Tablet Velakast) by Hetero is a combination of sofosbuvir and velpatasvir and is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It is also used with another antiviral medication (ribavirin). These drugs work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer. Velakast Sofosbuvir 400 mg & Velpatasvir 100 mg Indication: Sofosbuvir 400 mg & velpatasvir 100 mg is used alone or with ribavirin to treat chronic hepatitis C. Sofosbuvir is in a class of antiviral medications called nucleotide hepatitis C virus (HCV) NS5B polymerase inhibitors. Velpatasvir is in a class of antiviral medications called HCV NS5A replication complex inhibitors. The combination of sofosbuvir and Velpatasvir works by stopping the virus that causes hepatitis C from spreading inside the body.
SECOND FLOOR, OFFICE NO.01, PORTION-G, PLOT NO.37, BLOCK-8, Najafgarh Road, Kirti Nagar Industrial Area, New Delhi, West Delhi, Delhi, 110015
Send your enquiry to supplier
Related Products
Sofocure V Sofosbuvir Velpatasvir Tablets, 400 mg+ 100 mg
₹ 6,500 / Bottle
| Composition : Velpatasvir and Sofosbuvir |
| Dosage Form : Tablet |
| Manufacturer By : Emcure |
| Packaging Type : Bottle |
250mg Hepcvel Velpatasvir Sofosbuvir Tablet
₹ 7,500 / Box
| Composition : Sofosbuvir 400 mg & Velpatasvir 100 mg |
| Form : Tablet |
| Shelf life : 24 Months |
| Strength : 250mg |
Customer Reviews
Submit your Reviews
Best Selling Products from Chawla Medicos
Velpanat Sofosbuvir And Velpatasvir Tablets, 400 mg/ 100 mg
₹ 6,500 / Bottle
| Brand : Velpanat |
| Composition : Sofosbuvir And Velpatasvir |
| Dosage Form : Tablet |
| Dose/Strength : 400 mg/ 100 mg |
₹ 350 / Vial
| Brand : Cisplat |
| Composition : Cisplain |
| Form : Injection |
| Injection Site : Sterile Solution for Single Dose Intravenous infusion |
₹ 2,000
| Manufacturer : Natco |
| Medicine Type : Allopathic |
| Pack Size : 40 capsules |
| Packaging Size : 40 Capsules |
₹ 950
| Availability : In Stock |
| Brand : Renocrit 4000IU Injection |
| Composition : Recombinant Human Erythropoietin Alfa (4000IU/ml) |
| Country of Origin : Made in India |
Molnatris Molnupiravir 200 mg Capsules
₹ 1,900 / Bottle
| Manufacturer : Mylan |
| Packaging Size : 40 Capsules |
| Shelf life : 24 Months |
| Strength : 200mg |
₹ 322 / Vial
| Brand : Cistero |
| Injection Site : Sterile Solution for Single Dose Intravenous Infusion |
| Made in Country : India |
| Strength/Dosage : 50 mg |
₹ 2,700 / Box
| Manufactured By : Glenmark |
| Medicine Type : Allopathic |
| Packaging Size : 1 x 10 Capsules |
| Shelf Life : 24 Months |
₹ 350
| Availability : In Stock |
| Brand : Sevcar |
| Dose/Strength : 400 mg |
| Manufactured By : Emcure |
Nintena Nintedanib 150 mg Capsules
₹ 750 / Box
| Brand Name : Nintena |
| Form : Capsule |
| Manufactured By : Sun Pharmaceuticals Industries Ltd |
| Medicine Type : Allopathic |
₹ 499 / Vial
| Availability : In Stock |
| Country of Origin : Made in India |
| Manufacturer : JASGUR LIFE SCIENCES LLP |
| Marketer : JASGUR LIFE SCIENCES LLP |
